Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

After a thorough examination, Hanaa was diagnosed with gyrate atrophy, a rare genetic condition, along with advanced ...

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Yemeni woman travels to UAE for life-changing treatment, reinforcing Abu Dhabi’s status as a global healthcare hub ...

Clearside Biomedical, Inc. announced upcoming presentations featuring data from its CLS-AX sub-group analyses from the Phase 2b ODYSSEY trial for the treatment of wet age-related macular ...

Diabetic macular edema remains an important cause of vision loss among patients with diabetes mellitus. Improved control of blood pressure and blood sugar, as well as photocoagulation, are ...

[45] *Included patients with macular edema due to various etiologies, including diabetes. NA = Not available. Stephen G. Schwartz, Bascom Palmer Eye Institute, University of Miami Miller School of ...

Second, the higher level of inflammation secondary to the more traumatic surgery means that the risk of cystoid macular edema (CME) rises from 1.4% for uncomplicated cataract surgeries to 7.3% in ...

The company says that in pre-clinical tests performed on 30 people with macular degeneration, all of the participants experienced a reading speed increase of at least 50% when using the glasses.